AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26395352 — intervention group
Group type: EXPERIMENTAL
Intervention: Glass ionomer cement (GIC)
Number of subjects: 16
Study 26395352 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 16
Study 24472331 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal dexmedetomidine
Number of subjects: 108
Study 24472331 — intervention group
Group type: COMPARATOR
Intervention: Oral midazolam
Number of subjects: 108
Study 22488208 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugar-free gum with casein phosphopeptide amorphous calcium phosphate (CPP-ACP)
Number of subjects: 0
Study 22488208 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugar-free gum without CPP-ACP
Number of subjects: 0
Study 22488208 — intervention group
Group type: COMPARATOR
Intervention: No-gum control
Number of subjects: 0
Study 20081109 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1 infusion (0.7 pmol.kg(‐1).min(‐1))
Number of subjects: 20
Study 17700437 — intervention group
Group type: EXPERIMENTAL
Intervention: Disc prosthesis
Number of subjects: 49
Study 17700437 — intervention group
Group type: COMPARATOR
Intervention: ACDF (anterior cervical discectomy and fusion)
Number of subjects: 49
Study 16231625 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed CPB system with aspiration of blood from the operation field via the cardiotomy suction line and active venting of the heart via a roller pump
Number of subjects: 0
Study 16231625 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed CPB system avoiding aspiration of blood from the operation field via the cardiotomy suction line, but with active venting of the heart
Number of subjects: 0
Study 16231625 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed system, avoidance of aspiration of blood from the operation field via the cardiotomy suction line and with passive venting of the heart into the collapsible venous reservoir
Number of subjects: 0
Study 16231625 — intervention group
Group type: COMPARATOR
Intervention: Avoidance of aspiration of blood via the cardiotomy suction line
Number of subjects: 0
Study 11867385 — intervention group
Group type: EXPERIMENTAL
Intervention: IV clonidine (3 microg/kg)
Number of subjects: 29
Study 11867385 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 29
Study 10372584 — intervention group
Group type: EXPERIMENTAL
Intervention: H&P-first group
Number of subjects: 315
Study 10372584 — intervention group
Group type: COMPARATOR
Intervention: H&P-last group
Number of subjects: 315
Study 7832347 — intervention group
Group type: EXPERIMENTAL
Intervention: Videotape group (received the 10-minute CPR instruction videotape)
Number of subjects: 8659
Study 7832347 — intervention group
Group type: COMPARATOR
Intervention: No-videotape group (did not receive the videotape)
Number of subjects: 8659
Study 7832347 — intervention group
Group type: EXPERIMENTAL
Intervention: Individuals who watched the videotape during cardiac arrests
Number of subjects: 8659
Study 1973387 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (PROP)
Number of subjects: 7
Study 1973387 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol (MET)
Number of subjects: 7
Study 1973387 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 7
Study 31622684 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient portal usage
Number of subjects: 301
Study 31189674 — intervention group
Group type: EXPERIMENTAL
Intervention: QCPR Classroom
Number of subjects: 642
Study 31189674 — intervention group
Group type: COMPARATOR
Intervention: Standard CPR training (Control)
Number of subjects: 642
Study 27885247 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducational website (UTSMed) providing mental health literacy and cognitive behavioral skills; duration not specified.
Number of subjects: 313
Study 27885247 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention); duration not specified.
Number of subjects: 313
Study 26540491 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium Respimat 2.5 or 5 μg
Number of subjects: 6966
Study 26540491 — intervention group
Group type: COMPARATOR
Intervention: Tiotropium HandiHaler 18 μg
Number of subjects: 6966
Study 23913464 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhythm control strategy (antiarrhythmic medication and/or electrical cardioversion)
Number of subjects: 413
Study 23913464 — intervention group
Group type: COMPARATOR
Intervention: Rate control strategy
Number of subjects: 413
Study 23913464 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhythm control strategy
Number of subjects: 413
Study 21445603 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity (HI) resistance exercise
Number of subjects: 11
Study 21445603 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Intensity (LI) resistance exercise
Number of subjects: 11
Study 21445603 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Intensity Blood Flow Restricted (LI-BFR) resistance exercise
Number of subjects: 11
Study 19736281 — intervention group
Group type: COMPARATOR
Intervention: Therapeutic interventions
Number of subjects: 167
Study 19736281 — intervention group
Group type: COMPARATOR
Intervention: Trials without exclusions
Number of subjects: 167
Study 17090821 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous bone marrow mesenchymal stem cell therapy
Number of subjects: 45
Study 17090821 — intervention group
Group type: COMPARATOR
Intervention: Control group (PCI only)
Number of subjects: 45
Study 15001902 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenoxybenzamine 0.25 mg/kg on cardiopulmonary bypass
Number of subjects: 71
Study 15001902 — intervention group
Group type: COMPARATOR
Intervention: Control (no phenoxybenzamine)
Number of subjects: 71
Study 11722291 — intervention group
Group type: EXPERIMENTAL
Intervention: Active cycle of breathing techniques (ACBT) assisted by a physiotherapist
Number of subjects: 15
Study 11722291 — intervention group
Group type: COMPARATOR
Intervention: Active cycle of breathing techniques (ACBT) performed independently by the patient
Number of subjects: 15
Study 9374816 — intervention group
Group type: EXPERIMENTAL
Intervention: High hydration (HighH) - 2.0 ml water/kg body weight every 30 min
Number of subjects: 8
Study 9374816 — intervention group
Group type: COMPARATOR
Intervention: Low hydration (LowH) - 0.25 ml water/kg body weight every 30 min
Number of subjects: 8
Study 7695068 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzyme‐linked immunosorbent assay (ELISA) for measuring IgG subclasses
Number of subjects: 317
Study 7695068 — intervention group
Group type: COMPARATOR
Intervention: Radial immunodiffusion (RID) methods
Number of subjects: 317
Study 3539523 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP titration based on PaO2 < 65 torr with FIO2 of 0.45
Number of subjects: 38
Study 3539523 — intervention group
Group type: COMPARATOR
Intervention: PEEP titration until PaO2/FIO2 > 300 or Qsp/Qt < 0.20
Number of subjects: 38
Study 30474216 — intervention group
Group type: EXPERIMENTAL
Intervention: rhDNase
Number of subjects: 0
Study 30474216 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 28603468 — intervention group
Group type: EXPERIMENTAL
Intervention: Formulated milk product containing 9 g milk protein (FMP)
Number of subjects: 20
Study 28603468 — intervention group
Group type: COMPARATOR
Intervention: Isoenergetic carbohydrate placebo (CHO)
Number of subjects: 20
Study 25058380 — intervention group
Group type: EXPERIMENTAL
Intervention: Live related limbal allograft (Lr‐CLAL)
Number of subjects: 20
Study 25058380 — intervention group
Group type: COMPARATOR
Intervention: Cadaveric keratolimbal allograft (KLAL)
Number of subjects: 20
Study 23266603 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual search attentional bias modification (ABM) training
Number of subjects: 40
Study 23266603 — intervention group
Group type: COMPARATOR
Intervention: Control training
Number of subjects: 40
Study 21723567 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,25(OH)(2) Vitamin D
Number of subjects: 132
Study 18327986 — intervention group
Group type: EXPERIMENTAL
Intervention: darunavir/r (600/100 mg bid)
Number of subjects: 458
Study 16801663 — intervention group
Group type: EXPERIMENTAL
Intervention: Haplotypes ‐2578‐A/‐1154‐A/‐634‐G or ‐2578‐A/‐1154‐G/‐634‐G in the VEGF gene
Number of subjects: 580
Study 16801663 — intervention group
Group type: EXPERIMENTAL
Intervention: Promoter SNP‐1154 (rs1570360)
Number of subjects: 580
Study 16801663 — intervention group
Group type: COMPARATOR
Intervention: Control group (628 individuals)
Number of subjects: 580
Study 14733474 — intervention group
Group type: EXPERIMENTAL
Intervention: Esthetic crowns
Number of subjects: 10
Study 14733474 — intervention group
Group type: COMPARATOR
Intervention: Stainless steel crowns (SSC)
Number of subjects: 10
Study 10946892 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% T gel (50 or 100 mg/day)
Number of subjects: 227
Study 10946892 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% T gel (100 mg/day)
Number of subjects: 227
Study 10946892 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% T gel (50 mg/day)
Number of subjects: 227
Study 10946892 — intervention group
Group type: COMPARATOR
Intervention: T patch (5 mg/day)
Number of subjects: 227
Study 10946892 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% T gel
Number of subjects: 227
Study 10946892 — intervention group
Group type: COMPARATOR
Intervention: T patch
Number of subjects: 227
Study 9005385 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyproterone acetate
Number of subjects: 24
Study 9005385 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 24
Study 9005385 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 24
Study 9005385 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene and gonadotrophin (pure FSH)
Number of subjects: 24
Study 9005385 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study 1457767 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (25 mg three times daily)
Number of subjects: 0
Study 1457767 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 6749206 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional high-dose prednisone
Number of subjects: 62
Study 6749206 — intervention group
Group type: COMPARATOR
Intervention: Cytotoxic drugs
Number of subjects: 62
Study 29369458 — intervention group
Group type: EXPERIMENTAL
Intervention: Celeriac cultivar 'Anita'
Number of subjects: 16
Study 29369458 — intervention group
Group type: EXPERIMENTAL
Intervention: Celeriac cultivar 'Prinz'
Number of subjects: 16
Study 27055799 — intervention group
Group type: EXPERIMENTAL
Intervention: Self‐made single‐tube double lumen 'H shaped' drainage tube (Group A)
Number of subjects: 56
Study 27055799 — intervention group
Group type: COMPARATOR
Intervention: Traditional silicone drainage tube (Group B)
Number of subjects: 56
Study 25666998 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous iron sucrose (200mg/mL weekly for five weeks)
Number of subjects: 60
Study 23085502 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational therapy home program (OTHP) for 20 weeks, average 15 min per session
Number of subjects: 0
Study 23085502 — intervention group
Group type: COMPARATOR
Intervention: No OTHP
Number of subjects: 0
Study 21095115 — intervention group
Group type: EXPERIMENTAL
Intervention: CNS-directed therapy with intravenous methotrexate (5 g/sqm) in 4-10 courses and intrathecal methotrexate injections (10-20), no cranial irradiation.
Number of subjects: 2025
Study 19011778 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-molecular-weight hydroxyethyl starch (HES) at 2 ml x kg(‐1) x h(‐1) during surgery and 1 ml x kg(‐1) x h(‐1) after surgery, plus acetated Ringer's solution (AR) to maintain CVP at 5 mm Hg
Number of subjects: 21
Study 19011778 — intervention group
Group type: COMPARATOR
Intervention: Acetated Ringer's solution (AR) to maintain CVP at 3-5 mmHg
Number of subjects: 21
Study 19011778 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-molecular-weight hydroxyethyl starch (HES)
Number of subjects: 21
Study 19011778 — intervention group
Group type: COMPARATOR
Intervention: Acetated Ringer's solution (AR)
Number of subjects: 21
Study 16980114 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated whole-virion influenza A (H5N1) vaccine with 1.25 microg (24), 2.5 microg (24), 5 microg (24), or 10 microg (24) haemagglutinin per dose with aluminium hydroxide adjuvant
Number of subjects: 120
Study 16980114 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=24)
Number of subjects: 120
Study 15554283 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha port/laparoscope image
Number of subjects: 14
Study 10676669 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine 9 g daily for one month
Number of subjects: 10
Study 10676669 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 9424647 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous ethanol injection (PEI)
Number of subjects: 290
Study 9424647 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoembolization (CEAT)
Number of subjects: 290
Study 9424647 — intervention group
Group type: EXPERIMENTAL
Intervention: PEI
Number of subjects: 290
Study 9424647 — intervention group
Group type: EXPERIMENTAL
Intervention: CEAT
Number of subjects: 290
Study 9424647 — intervention group
Group type: COMPARATOR
Intervention: No treatment (NT)
Number of subjects: 290
Study 8457093 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical CPR
Number of subjects: 15
Study 8457093 — intervention group
Group type: COMPARATOR
Intervention: Manual CPR
Number of subjects: 15
Study 3522474 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 42
Study 3522474 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 29143193 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette Purchase Task (CPT) for depressed smokers
Number of subjects: 165
Study 29143193 — intervention group
Group type: COMPARATOR
Intervention: Cigarette Purchase Task (CPT) for non-depressed smokers
Number of subjects: 165
Study 26331581 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban (5 mg single oral dose administered twice to subjects with ESRD, once before hemodialysis and once after hemodialysis)
Number of subjects: 16
Study 26331581 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban (5 mg single oral dose administered before and after hemodialysis)
Number of subjects: 16
Study 26331581 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects (control group)
Number of subjects: 16
Study 26331581 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban (5 mg single oral dose)
Number of subjects: 16
Study 23728476 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive training program (virtual reality, task trainer, and mannequin simulator)
Number of subjects: 45
Study 23728476 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fidelity program (mannequin)
Number of subjects: 45
Study 23728476 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fidelity program (virtual reality)
Number of subjects: 45
Study 21473794 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous cumulus cell embryo co-culture and transfer at day 5-6
Number of subjects: 432
Study 21473794 — intervention group
Group type: COMPARATOR
Intervention: Classical culture and day 3 transfer
Number of subjects: 432
Study 21626819 — intervention group
Group type: EXPERIMENTAL
Intervention: Axamon (20 mg 3 times a day for 12 weeks)
Number of subjects: 50
Study 21626819 — intervention group
Group type: COMPARATOR
Intervention: Basic therapy
Number of subjects: 50
Study 18633022 — intervention group
Group type: EXPERIMENTAL
Intervention: Palonosetron 0.075 mg
Number of subjects: 574
Study 18633022 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 574
Study 15896281 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) plus continued psychopharmacology
Number of subjects: 31
Study 15896281 — intervention group
Group type: COMPARATOR
Intervention: Continued psychopharmacology alone
Number of subjects: 31
Study 11735172 — intervention group
Group type: EXPERIMENTAL
Intervention: levamisole/UFT chemotherapy (N=29)
Number of subjects: 65
Study 11735172 — intervention group
Group type: COMPARATOR
Intervention: Control group (N=34)
Number of subjects: 65
Study 9440632 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg/day lansoprazole
Number of subjects: 186
Study 9440632 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 186
Study 8306000 — intervention group
Group type: EXPERIMENTAL
Intervention: MEDLINE search strategy
Number of subjects: 5583
Study 8306000 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of MEDLINE and selective hand search
Number of subjects: 5583
Study 8306000 — intervention group
Group type: COMPARATOR
Intervention: Hand search of entire journals
Number of subjects: 5583
Study 8306000 — intervention group
Group type: COMPARATOR
Intervention: MEDLINE search
Number of subjects: 5583
Study 3597149 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy and misonidazole (1.5 gm/m2 daily 4‐6 hr before each treatment)
Number of subjects: 214
Study 3597149 — intervention group
Group type: COMPARATOR
Intervention: Radiation therapy alone
Number of subjects: 214
Study 3597149 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy and misonidazole
Number of subjects: 214
Study 30092666 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 μg/kg dexmedetomidine via intravenous pump
Number of subjects: 31
Study 26040282 — intervention group
Group type: EXPERIMENTAL
Intervention: Distraction cards
Number of subjects: 120
Study 26040282 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to the music of cartoon
Number of subjects: 120
Study 23635803 — intervention group
Group type: EXPERIMENTAL
Intervention: Disulfiram (250 mg/day)
Number of subjects: 68
Study 23635803 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study 21628421 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose data-filtering system with automatic response software
Number of subjects: 79
Study 21628421 — intervention group
Group type: COMPARATOR
Intervention: Control group (manual contact by physicians)
Number of subjects: 79
Study 18692841 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (LDA) 100 mg daily
Number of subjects: 60
Study 18692841 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids 4 g daily
Number of subjects: 60
Study 18692841 — intervention group
Group type: EXPERIMENTAL
Intervention: LDA plus Omega-3
Number of subjects: 60
Study 17229604 — intervention group
Group type: COMPARATOR
Intervention: Ablation alone (Group A)
Number of subjects: 255
Study 17229604 — intervention group
Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream monotherapy (Group B)
Number of subjects: 255
Study 17229604 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined ablation followed by topical imiquimod (Group C)
Number of subjects: 255
Study 12547874 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg (A10)
Number of subjects: 198
Study 12547874 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg (A80)
Number of subjects: 198
Study 12547874 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 198
Study 10979057 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin alone (INR maintained at 1.4 or more)
Number of subjects: 2545
Study 10979057 — intervention group
Group type: COMPARATOR
Intervention: Warfarin and aspirin (75 mg/d)
Number of subjects: 2545
Study 9024712 — intervention group
Group type: EXPERIMENTAL
Intervention: NFL (Mitoxantrone, 5-fluorouracil, high dose leucovorin)
Number of subjects: 128
Study 9024712 — intervention group
Group type: COMPARATOR
Intervention: CMF (Cyclophosphamide, Methotrexate, 5-fluorouracil)
Number of subjects: 128
Study 9024712 — intervention group
Group type: EXPERIMENTAL
Intervention: NFL
Number of subjects: 128
Study 9024712 — intervention group
Group type: COMPARATOR
Intervention: CMF
Number of subjects: 128
Study 9024712 — intervention group
Group type: EXPERIMENTAL
Intervention: NFL and CMF
Number of subjects: 128
Study 8336248 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine dentifrice applied undiluted via toothshield
Number of subjects: 88
Study 8336248 — intervention group
Group type: COMPARATOR
Intervention: Placebo dentifrice applied undiluted via toothshield
Number of subjects: 88
Study 3595067 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg isosorbide‐5‐mononitrate (IS‐5MN)
Number of subjects: 12
Study 3595067 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg isosorbide‐5‐mononitrate (IS‐5MN)
Number of subjects: 12
Study 3595067 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 29335018 — intervention group
Group type: EXPERIMENTAL
Intervention: Danggwijagyaksan (DJS)
Number of subjects: 34
Study 29335018 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 27845765 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal Oxytocin (OT) administration
Number of subjects: 0
Study 25636895 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-inflating bag (SIB)
Number of subjects: 90
Study 25636895 — intervention group
Group type: COMPARATOR
Intervention: T-piece resuscitator (TPR)
Number of subjects: 90
Study 25636895 — intervention group
Group type: COMPARATOR
Intervention: T-piece resuscitator (TPR) in neonates <34 weeks
Number of subjects: 90
Study 22935722 — intervention group
Group type: EXPERIMENTAL
Intervention: Belief in having a gene associated with alcoholism
Number of subjects: 0
Study 20493557 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregnenolone (titrated to 100mg/day)
Number of subjects: 70
Study 20493557 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 18463376 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 751
Study 18463376 — intervention group
Group type: COMPARATOR
Intervention: Insulin
Number of subjects: 751
Study 22207098 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily care activities (washing, dressing, transfer)
Number of subjects: 40
Study 16138670 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (BTX‐A) only
Number of subjects: 39
Study 16138670 — intervention group
Group type: COMPARATOR
Intervention: Placebo injection plus casting
Number of subjects: 39
Study 16138670 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin A plus casting (BTX‐A + casting)
Number of subjects: 39